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Like life itself, synthetic biology began with unicellular organisms. Early synthetic 
biologists built genetic circuits in model prokaryotes and yeast because of their relative 
biological simplicity and ease of genetic manipulation. With superior genetic tools, faster 
generation times, and better-understood endogenous gene expression machinery, prokar-
yotes and yeast were (and remain) appealing hosts for the engineering of synthetic systems. 
Now in its second decade, synthetic biology in unicellular organisms has produced myriad 
synthetic genetic circuits, a number of industrial applications, and fundamental new 
biological insights unlikely to have emerged from nonsynthetic approaches.
Yet, the biological complexity that made metazoans less attractive for early synthetic 
biology is precisely what makes these organisms exciting targets for a new generation. 
Multicellular phenomena such as development (with its linkage of growth, morphogenesis, 
and differentiation) seem dauntingly complex and have thus far evaded comprehensive 
understanding through biological approaches that rely on perturbations to natural systems. 
Synthetic approaches based on bottom-up reconstitution of these phenomena promise 
intimate insights, complementary to those obtained through traditional methods. At the same 
time, therapeutic applications of synthetic biology will have to function within, and ideally 
exploit, the many complex aspects of multicellular systems. For all these reasons, synthetic 
biology of animal cells has become an exciting, albeit challenging, frontier.
Today, engineering animal cells remains primitive, based on slow, imprecise, and generally 
clunky tools. How will we reach the point where we can routinely design, build, and analyze 
synthetic genetic circuits that operate within the inherently multicellular contexts of 
developing embryos and mature tissues? There is some hope: major new advances in DNA 
synthesis and assembly enable construction of increasingly elaborate DNA constructs. New 
tools for genome targeting, particularly site-specific recombinases and programmable 
systems such as CRISPRs and TALEs, greatly improve our control of genome editing.
Yet major technical challenges remain. The predictability and tunability of synthetic genetic 
elements remain poor. We often lack general strategies for isolating synthetic systems from 
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the host cell and from each other. Locus-specific effects and clone-to-clone variation often 
limit systematic studies that require comparisons among different genotypes. Beyond these 
problems of implementation, our molecular toolbox remains limited. We do not have many 
regulatable transcription factors that work well in mammalian cells. We have few orthogonal 
signaling components that can link arbitrary intracellular pathways and enable cells to 
coordinate with one another in a controlled fashion; we also lack general and robust methods 
for integration of synthetic systems with the natural machinery of their hosts. At the end of 
the day, the time it takes to go from in silico design to stable cell lines containing full 
circuits, let alone whole animals, remains painfully long. In short, we need to better 
understand the components we do have, grow the number of components in our toolbox, 
tackle site-specific effects and reduce integration site variability, and speed the entire 
process up by an order of magnitude. Such advances will help us to tackle what is perhaps 
the biggest problem of all— our lack of understanding of fundamental circuit design 
principles. Those principles will emerge only through construction and rigorous analysis of 
new synthetic circuits, enabled by new technologies and an expanding synthetic biology 
community.
In this issue, we bring together four papers that bring the dream of synthetic multicellular 
biology closer. First, in order to increase the repertoire of regulatory components available, 
Stanton et al. identify homologues of the popular TetR repressor that target orthogonal 
binding sites; as with TetR, variants of these homologues can be deployed as repressors or 
activators in vivo. The activity of one such homologue, PhlF, can be controlled by the small 
molecule DAPG, analogously to the control of TetR by doxycycline, thus introducing a 
much-needed new inducible system for mammalian synthetic biology.
While new transcription factors are of great utility, coupling their activity to synthetic or 
natural environmental cues remains a major challenge for the field. Daringer et al. address 
this issue by developing a Modular Extracellular Sensor Architecture (MESA) that couples 
programmable detection of extracellular ligands to the induction of reporter gene expression 
through controlled protease recruitment, similarly to the Tango method previously 
demonstrated for detecting ligands of G-protein coupled receptors, receptor tyrosine kinases, 
and steroid hormone receptors.1 MESA entails construction of two synthetic transmembrane 
fusion proteins with conditionally dimerizing extracellular sensor domains and an 
intracellular domain that is either a protease or a transcription factor with a linker that 
contains a protease recognition site; dimerization of the sensor domains brings the protease 
in proximity to the transcription factor domain, which it then cleaves off of the fusion 
protein, releasing it for transit to the nucleus. Alternatively, the two transmembrane proteins 
can carry separate N- and C-terminal domains of the protease, with dimerization 
reconstituting protease activity that releases a transcription factor tethered to a third 
transmembrane protein. The MESA system opens up new possibilities for creating synthetic 
intercellular signaling circuits in mammalian cells.
A third paper addresses some of the key challenges of genomic integration of synthetic 
circuits. We need the ability to stably integrate constructs into precisely defined sites, 
subject to minimal interference from the host genome. Human artificial chromosomes 
(HACs) represent promising vectors for constructing complex genetic circuits because they 
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are stably inherited (similarly to normal chromosomes), can accommodate large genetic 
cargo, minimize undesired interference with transgenes and endogenous genes, and, once 
constructed, can in principle be transferred among cell lines. However, the utility of HACs 
in creating transgenic mice is limited by variable retention rates in mice tissue. Here, 
Takiguchi et al. report the development of a mouse artificial chromosome (MAC) 
employing a native mouse centromere and show that this MAC is stably maintained in a 
variety of tissues in transgenic mice. The authors also develop a derivative of the MAC that 
contains five acceptor sites (landing pads) that can be targeted by corresponding 
recombinases for site-specific introduction of cargo. These MACs promise increased 
versatility and control, both in whole animals and in cell culture.
While these three papers represent advances at the cellular level, the fourth paper tackles 
synthetic biology at a totally different scale—entire populations of organisms—by 
expanding an elegant synthetic biology approach for controlling insect-borne disease. The 
Hay group previously developed a synthetic self-ish genetic element called Medea that can 
be used to drive population replacement in Drosophila by killing non-Medea-bearing 
progeny of Medea-bearing mothers.2 Consequently, a minority of Medea flies is sufficient to 
rapidly spread the element through a larger wild-type population, enabling them to 
potentially spread a disease-inhibiting genetic cargo. The original Medea worked through 
microRNA-mediated silencing of a maternally expressed transcript, myd88, that was 
required for zygotic development, coupled with zygotic expression of a rescue transgene. 
Akbari et al. now report two novel Medea systems based on the same principle but targeting 
different pathways. An expanded Medea toolbox enables new strategies for mutational 
stability (i.e., dealing with inactivating mutations in any one Medea element) and for the 
controlled elimination of a given element from the population in case the whole enterprise 
goes awry. The authors also use mathematical modeling to demonstrate how specially 
designed Medea constructs could induce population suppression in response to an 
environmental cue, such as diapause-inducing drought, following initial replacement of the 
population with Medea-bearing animals. This work will provide a foundation for future 
efforts aimed at real-world disease vector control. It is also an extraordinary example of how 
a single synthetic biology project can cut across multiple levels of biological complexity, 
from a gene circuit to a developmental process to population dynamics.
Together, these papers exemplify a few of the remarkably diverse approaches currently 
being pursued to realize the many promises of multicellular synthetic biology. Looking 
ahead, there are a mind-boggling number of systems, approaches, and applications to 
explore. As we develop the field, we need to pursue new techniques and applications with 
equal parts imagination and rigor so that multicellular synthetic biology realizes it potential 
as both science and engineering—where the systematic construction of synthetic systems 
drives new biological understanding, which in turn advances our synthetic potential.
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